Ulrich Herrlinger

HSV‐1 infected cell proteins influence tetracycline‐regulated transgene expression

N. Rainov, C. Fraefel, P. Pechan, 2000, The journal of gene medicine.

Combined HSV‐1 recombinant and amplicon piggyback vectors: replication‐competent and defective forms, and therapeutic efficacy for experimental gliomas

A. Jacobs, X. Breakefield, P. Pechan, 1999, The journal of gene medicine.

Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas.

P. Black, N. Rainov, Shaoxiong Liu, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Targeting gene therapy vectors to CNS malignancies.

R. Weissleder, X. Breakefield, N. Rainov, 1998, Journal of neurovirology.

Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma.

A. Jacobs, C. Woiciechowsky, A. Quiñones, 2000, Human gene therapy.

Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.

S. Larson, R. Blasberg, A. Jacobs, 2001, Cancer research.

Long-term survival in a rodent model of disseminated brain tumors by combined intrathecal delivery of herpes vectors and ganciclovir treatment.

C. Kramm, E. Chiocca, N. Rainov, 1996, Human gene therapy.

Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy.

A. Jacobs, C. Kramm, E. Chiocca, 1997, Human gene therapy.